Inovio Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
INO Inovio Pharmaceuticals Inc
GOLD Barrick Gold Corp
AMZN Amazon.com Inc
NFLX Netflix Inc
CDTX Cidara Therapeutics Inc
XBTAX BlackRock Long Term Municipal Advantage Trust
PBYA Probility Media Corp
RA Brookfield Real Assets Income Fund Inc.
PAA Plains All American Pipeline LP
$ESDOWD DOW JONES SPAIN STK US$ NDX
Go

Health Care : Biotechnology | Small Cap Blend
Company profile

Inovio Pharmaceuticals, Inc. (Inovio) is a late-stage biotechnology company, which is involved in developing deoxyribonucleic acid (DNA) immunotherapies and vaccines focused on treating and preventing cancers and infectious diseases. The Company's DNA-based immunotherapies, in combination with its electroporation delivery devices, generates immune responses, in particular T cells, in the body to fight target diseases. It has completed, current or planned clinical programs of its SynCon immunotherapies for human papillomavirus (HPV)-caused pre-cancers and cancers, influenza, prostate cancer, breast/lung/pancreatic cancer, hepatitis C virus (HCV), hepatitis B virus (HBV), human immunodeficiency virus (HIV), Ebola, Middle East Respiratory Syndrome (MERS) and Zika virus. With its immunotherapy platform, as well as with its CELLECTRA electroporation delivery technology, it has a pipeline of pre-clinical and clinical stage products that have generated in vivo immune responses.

Closing Price
$21.45
Day's Change
1.72 (8.72%)
Bid
--
Ask
--
B/A Size
--
Day's High
22.48
Day's Low
19.90
Volume
(Light)
Volume:
52,608,963

10-day average volume:
85,813,188
52,608,963

Thinking about trading stocks or options in Inovio Pharmaceuticals, Canopy Growth Corp, United Airlines, Rockwell Automation, or Wells Fargo?

9:31 am ET May 27, 2020 (PR Newswire) Print

InvestorsObserver issues critical PriceWatch Alerts for INO, CGC, UAL, ROK, and WFC.

https://mma.prnewswire.com/media/1086590/InvestorsObserver_Logo.jpg

Click a link below then choose between in-depth options trade idea report or a stock score report.

Options Report - Ideal trade ideas on up to seven different options trading strategies. The report shows all vital aspects of each option trade idea for each stock.

Stock Report - Measures a stock's suitability for investment with a proprietary scoring system combining short and long-term technical factors with Wall Street's opinion including a 12-month price forecast.

-- INO: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=INO&prnumber=052720201

-- CGC: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=CGC&prnumber=052720201

-- UAL: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=UAL&prnumber=052720201

-- ROK: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=ROK&prnumber=052720201

-- WFC: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=WFC&prnumber=052720201

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

https://c212.net/c/img/favicon.png?sn=CG17749&sd=2020-05-27

View original content to download multimedia:http://www.prnewswire.com/news-releases/thinking-about-trading-stocks-or-options-in-inovio-pharmaceuticals-canopy-growth-corp-united-airlines-rockwell-automation-or-wells-fargo-301065563.html

SOURCE InvestorsObserver

https://rt.prnewswire.com/rt.gif?NewsItemId=CG17749&Transmission_Id=202005270931PR_NEWS_USPR_____CG17749&DateId=20200527

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.